norethindrone has been researched along with Arterial Occlusive Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adam, H; Schirmer, B | 1 |
| Friedman, S; Golan, A; Goldman, J; Shoenfeld, A | 1 |
3 other study(ies) available for norethindrone and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Norgestrel, increased lipids: fact or "marketing monster"?
Topics: Americas; Arterial Occlusive Diseases; Arteriosclerosis; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Developed Countries; Disease; Ethinyl Estradiol; Family Planning Services; Levonorgestrel; Lipids; Norethindrone; Norgestrel; North America; Physiology; United States; Vascular Diseases | 1989 |
[Adverse effects of oral contraceptives].
Topics: Arterial Occlusive Diseases; Chlormadinone Acetate; Contraceptives, Oral; Ethinyl Estradiol; Exanthema; Female; Humans; Mestranol; Norethindrone; Porphyrias; Thrombosis; Urticaria | 1973 |
Acute opthalmologic complications during the use of oral contraceptives.
Topics: Adult; Amino Alcohols; Arterial Occlusive Diseases; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Drug Combinations; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Humans; Mestranol; Nicotinic Acids; Norethindrone; Retinal Artery; Theophylline; Vision Disorders; Warfarin | 1974 |